{"abstract":"The Food and Drug Administration (FDA) is announcing the revocation of the Emergency Use Authorization (EUA) (the Authorization) issued to Eli Lilly and Co. (Lilly), for bamlanivimab and etesevimab administered together. FDA revoked the Authorization on December 14, 2023, under the Federal Food, Drug, and Cosmetic Act (FD&C Act). The revocation, which includes an explanation of the reasons for the revocation, is reprinted in this document.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2024/03/11/2024-05085.html","cfr_references":[],"citation":"89 FR 17475","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":"The Authorization is revoked as of December 14, 2023.","disposition_notes":null,"docket_ids":["Docket No. FDA-2023-N-2057"],"dockets":[{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2024-03-11","updated_at":"2024-09-03T16:46:40.505-04:00","comment_url":"https://www.regulations.gov/commenton/FDA-2023-N-2057-0002","allow_late_comments":false,"id":"FDA-2023-N-2057-0002","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2023-N-2057","title":"Revocation of Emergency Use of a Drug During the COVID-19 Pandemic; Availability"}],"document_number":"2024-05085","effective_on":null,"end_page":17477,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2024/03/11/2024-05085.xml","html_url":"https://www.federalregister.gov/documents/2024/03/11/2024-05085/revocation-of-emergency-use-of-a-drug-product-during-the-covid-19-pandemic-availability","images":{"EN11MR24.002":{"large":"https://img.federalregister.gov/EN11MR24.002/EN11MR24.002_large.png","medium":"https://img.federalregister.gov/EN11MR24.002/EN11MR24.002_medium.png","original_size":"https://img.federalregister.gov/EN11MR24.002/EN11MR24.002_original_size.png"},"EN11MR24.003":{"large":"https://img.federalregister.gov/EN11MR24.003/EN11MR24.003_large.png","medium":"https://img.federalregister.gov/EN11MR24.003/EN11MR24.003_medium.png","original_size":"https://img.federalregister.gov/EN11MR24.003/EN11MR24.003_original_size.png"}},"images_metadata":{"EN11MR24.002":{"large":{"identifier":"EN11MR24.002","content_type":"image/png","size":114177,"width":823,"sha":"18300c05969d55713f3f687d788fddf5","url":"https://img.federalregister.gov/EN11MR24.002/EN11MR24.002_large.png","height":1207},"medium":{"identifier":"EN11MR24.002","content_type":"image/png","size":34258,"width":395,"sha":"ef9d4b05b0760236f73f1e450f711bba","url":"https://img.federalregister.gov/EN11MR24.002/EN11MR24.002_medium.png","height":579},"original_size":{"identifier":"EN11MR24.002","content_type":"image/png","size":68070,"width":1490,"sha":"220a0fdfc5b42add98ac766c704c240b","url":"https://img.federalregister.gov/EN11MR24.002/EN11MR24.002_original_size.png","height":2186}},"EN11MR24.003":{"large":{"identifier":"EN11MR24.003","content_type":"image/png","size":18811,"width":746,"sha":"ea23bf62b46292a6968044131fbed0c5","url":"https://img.federalregister.gov/EN11MR24.003/EN11MR24.003_large.png","height":344},"medium":{"identifier":"EN11MR24.003","content_type":"image/png","size":5572,"width":351,"sha":"7ad362cfc6873e0459702080f82b44d5","url":"https://img.federalregister.gov/EN11MR24.003/EN11MR24.003_medium.png","height":162},"original_size":{"identifier":"EN11MR24.003","content_type":"image/png","size":11965,"width":1324,"sha":"d3674b6206cc15bd2debcf0c63848add","url":"https://img.federalregister.gov/EN11MR24.003/EN11MR24.003_original_size.png","height":611}}},"json_url":"https://www.federalregister.gov/api/v1/documents/2024-05085?publication_date=2024-03-11","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2024-03-11/2024-05085/mods.xml","not_received_for_publication":null,"page_length":3,"page_views":{"count":420,"last_updated":"2026-07-27 12:15:04 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-03-11/pdf/2024-05085.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-05085.pdf?1709905540","publication_date":"2024-03-11","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2024/03/11/2024-05085.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_count":0,"agency_id":"FDA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2023-N-2057","supporting_documents_count":0,"docket_id":"FDA-2023-N-2057","document_id":"FDA-2023-N-2057-0002","regulation_id_number":null,"title":"Revocation of Emergency Use of a Drug During the COVID-19 Pandemic; Availability","checked_regulationsdotgov_at":"2024-03-12T14:00:09Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":17475,"subtype":null,"title":"Revocation of Emergency Use of a Drug Product During the COVID-19 Pandemic; Availability","toc_doc":"Drug Product during the COVID19 Pandemic; Revocation","toc_subject":"Emergency Use Authorization:\n","topics":[],"type":"Notice","volume":89}